Clinical Trials Directory

Trials / Completed

CompletedNCT06059950

Feasibility of the Mindfulness Flow Program (MFP) on Archers

Examining the Feasibility of the Mindfulness Flow Program (MFP) on Archers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
Hong Kong Metropolitan University · Academic / Other
Sex
All
Age
13 Years – 55 Years
Healthy volunteers
Not accepted

Summary

Mindfulness-based interventions have gained popularity among elite athletes, but their effectiveness for enhancing archery performance remains inconsistent. This study examined the feasibility of a 12-week mindfulness flow program (MFP) specifically designed for archers, and assessed the effect of the MFP on shooting performance. The intervention aims to enhance shooting performance, mindfulness, and the flow state, while reducing post-intervention anxiety.

Detailed description

The primary goal of the present study was to test the feasibility of a prototype mindfulness flow program (MFP), with 11 sessions conducted via Zoom video meeting and one in-person session of sport-specific session. Additionally, the program seeks to examine the psychological outcomes associated with the intervention specifically among archery athletes. It is anticipated that the experimental group will show reduced anxiety levels and increased levels of mindfulness and flow when comparing their baseline and post-intervention assessments. This study explores the potential of delivering mindfulness programs conveniently to sport populations via the internet, supplemented by one face-to-face sport-specific session to enhance mindfulness and improve sports performance among athletes.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMindfulness Flow ProgramThe mindfulness flow program (MFP) consisted of eleven 60-minute sessions via Zoom, with one session per week. Additionally, a 120-minute in-person sport-specific session were conducted.

Timeline

Start date
2021-03-20
Primary completion
2023-02-10
Completion
2023-09-17
First posted
2023-09-29
Last updated
2023-09-29

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT06059950. Inclusion in this directory is not an endorsement.